Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma

Journal of Surgical Oncology

Volumn 105, Issue 6, 2012, Pages 548-552

  Li, Hecheng ^a,b   Yang, Su ^a,b   Zhang, Yawei ^a,b   Xiang, Jiaqing ^a,b   Chen, Haiquan ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

esophageal cancer; survival; three field lymph node dissection; two field lymph node dissection

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CORRELATION ANALYSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LARYNGEAL LYMPH NODE METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LARYNX; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK; RETROSPECTIVE STUDIES; THORAX;

EID: 84859729341     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22148     Document Type: Article

References (26)

1. Nishihira T, Hirayama K, Mori S,: A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998; 175: 47-51.
2. Fujita H, Kakegawa T, Yamana H, et al.: Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg 1994; 18: 266-272.
3. Mizutani M, Murakami G, Nawata S, et al.: Anatomy of right recurrent nerve node: Why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat 2006; 28: 333-338.
4. Shiozaki H, Yano M, Tsujinaka T, et al.: Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus 2001; 14: 191-196.
5. Tabira Y, Yasunaga M, Tanaka M, et al.: Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg 2000; 191: 232-237.
6. Ueda Y, Shiozaki A, Itoi H, et al.: Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer. Oncol Rep 2006; 16: 1061-1066.
7. Hejna M, Raderer M,: Neoadjuvant therapy for resectable esophageal cancer. Z Gastroenterol 2005; 43: 1141-1147.
8. Lewis I,: The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg 1946; 34: 18-31.
9. Ellis FJ, Gibb SP, Watkins EJ,: Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg 1983; 198: 531-540.
10. Isono K, Sato H, Nakayama K,: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-420.
11. Kato H, Watanabe H, Tachimori Y, et al.: Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991; 51: 931-935.
12. Akiyama H, Tsurumaru M, Udagawa H, et al.: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-372, 372-373.
13. Fujita H, Kakegawa T, Yamana H, et al.: Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222: 654-662.
14. Kato H, Tachimori Y, Watanabe H, et al.: Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol 1996; 61: 267-272.
15. Tabira Y, Okuma T, Kondo K, et al.: Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 1999; 117: 239-245.
16. Udagawa H, Akiyama H,: Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus 2001; 14: 110-114.
17. Tachibana M, Kinugasa S, Yoshimura H, et al.: Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005; 189: 98-109.
18. Natsugoe S, Matsumoto M, Okumura H, et al.: Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbecks Arch Surg 2010; 395: 341-346.
19. Fang WT, Chen WH,: Current trends in extended lymph node dissection for esophageal carcinoma. Asian Cardiovasc Thorac Ann 2009; 17: 208-213.
20. Shim YM, Kim HK, Kim K,: Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010; 5: 707-712.
21. Isono K, Ochiai T, Okuyama K, et al.: The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy. Jpn J Surg 1990; 20: 151-157.
22. Rice TW,: Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000; 10: 471-485.
23. Jamieson GG, Lamb PJ, Thompson SK,: The role of lymphadenectomy in esophageal cancer. Ann Surg 2009; 250: 206-209.
24. Altorki NK, Skinner DB,: Occult cervical nodal metastasis in esophageal cancer: Preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg 1997; 113: 540-544.
25. Sharma S, Fujita H, Yamana H, et al.: Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagus. Surg Today 1994; 24: 410-414.
26. Tabira Y, Kitamura N, Yoshioka M, et al.: Significance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate. J Cardiovasc Surg (Torino) 1999; 40: 737-740.